Skip to content

Assessment of bidirectional neural conduction pathways and construction of a rehabilitation prediction model for stroke patients with BCI-exoskeleton systems

Assessment of bidirectional neural conduction pathways and construction of a rehabilitation prediction model for stroke patients with BCI-exoskeleton systems

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500105128
Enrollment
Unknown
Registered
2025-06-30
Start date
2025-07-20
Completion date
Unknown
Last updated
2025-07-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Interventions

BCI Group:On the basis of the control group, BCI training was administered. The treatment utilized a brain-computer interface rehabilitation training system. First, an electroencephalogram (EEG) cap w
Control Group:On the basis of the control group, conventional treatments were administered, including medication therapy, desktop cognitive rehabilitation therapy, motor therapy, psychotherapy, physic
BCI-TMS Group:Based on the BCI group, high-frequency (10Hz) repetitive transcranial magnetic stimulation (rTMS) was administered to the M1 area of the unaffected hemisphere.The patient was seated in a

Sponsors

The Fifth Affiliated Hospital of Zhengzhou University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria for stroke of the Fourth National Cerebrovascular Conference in 1995, and it is the first stroke (ischemic stroke or hemorrhagic stroke, diagnosed by head CT or MRI), and the onset time is less than 6 months; 2. Aged 18-80 years old; 3. Hemiplegia and walking dysfunction after stroke; 4. Sitting balance >= grade 2; 5. Acceptable cognitive function, MMSE>=21, able to execute 2-step instructions; 6. Be able and willing to participate in the study.

Exclusion criteria

Exclusion criteria: 1. Severe cognitive impairment, aphasia, or mental instability; 2. Ankle joint instability, or contracture, fracture, arthritis and other orthopedic diseases; 3. Diagnosis of peripheral neuropathy or peripheral vascular disease, with symptoms that prevent or limit walking or participation in the study; 4. Weight >100kg, height outside the range of 150-188cm; 5. Patients with severe heart and lung diseases who cannot tolerate the test; 6. Visual, hearing, and vestibular organ dysfunction; 7. Patients with severe ataxia symptoms; 8. Exposure to infectious diseases.

Design outcomes

Primary

MeasureTime frame
Functional Near-Infrared Spectroscopy;Fugl-Meyer Assessment;Action Research Arm Test;Montreal Cognitive Assessment;Hamilton Depression Rating Scale ;Motor Evoked Potential and Central Motor Conduction Time;Electroencephalogram data;

Secondary

MeasureTime frame
Adverse Event Rate;Modified Barthel Index;Kinesthetic and Visual Imagery Questionnaire;Wechsler Memory Scale;Attention Assessment;

Countries

China

Contacts

Public ContactDong Anqin

The Fifth Affiliated Hospital of Zhengzhou University

anqindong@163.com+86 187 0380 9920

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026